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Introduction 
 Dengue virus is arthropod-borne flavivirus that is widespread in 
many tropical and subtropical regions of the world (Gubler, 1998, 
2002; Hales, de Wet, Maindonald, & Woodward, 2002; Monath, 
1994; World Health Organization, 1997). According to the WHO 
classification, dengue infection is classified as dengue fever (DF) 
and dengue haemorrhagic fever (DHF)/dengue shock syndrome 
(DSS). DF is a self-limited illness that begins with a sudden temperature 
increase accompanied by headache, myalgia, macular rash, 
loss of appetite, nausea, vomiting, abdominal pain, metallic taste 
of food, change in psychological state and moderate thrombocytopenia 
(Gubler & Kuno, 1997). Due to the increase in the vascular 
permeability, some of DF patients might progress to DHF patients, 
who presents with some form of the haemorrhagic manifestations. 
According to the WHO, the criteria of DHF are fever, haemorrhagic 
tendencies, thrombocytopenia and haemoconcentration. Moreover, 
the WHO subdivides DHF into four categories: DHFI, DHFII, 
DHFIII and DHFIV. The positive tourniquet test is the only haemorrhagic 
manifestation of grade I, while grade II presents with spontaneous 
bleeding. Grade III has signs of circulatory failure, while 
grade IV presents with circulatory failure signs. Both grade III 
and IV are considered as DSS. 
 Recently, some studies showed that several difficulties have 
been faced by the clinicians to apply the WHO classification criteria 
(Bandyopadhyay, Lucy, & Kroeger, 2006; Xuan et al., 2004). 
A study conducted by Bandyopadhyay et al. (2006) reviewed 
the literature published between 1975 and 2005 for the classification 
of dengue disease suggested that the WHO criteria needs 
to the re-visiting. The difficulties reported by the clinicians to 
apply the four criteria of the DHF cases were the reason behind 
this suggestion. Another study (Xuan et al., 2004) declared that 
no validation of the WHO system has been attempted yet due 
to the absence of an independent diagnostic marker. Moreover, 
the overlapping in the major clinical features that differentiate 
DF from DHF makes the classification of dengue patients 
difficult. The study suggested that urgent research is needed 
in order to understand the pathophysiologic mechanisms underlying 
the various clinical manifestations seen in dengue 
infections. 
 Due to above-mentioned difficulties that have been faced by the 
implementation of the WHO system, many descriptive statistical 
studies were proposed and implemented different risk criteria or 
risk factor for the classification of dengue patients (Chai, Goh, 
Chan, el_Amin, & Lam, 2002; Ibrahim, 2005; Ibrahim, Taib, Wan 
Abas, Chan, & Sulaiman, 2005a; Kalayanarooj et al., 1997; Narayanan, 
Aravind, Ambikapathy, Prema, & Jeyapaul, 2003; Shivbalan, 
Anandnathan, Balasubramanian, Datta, & Amalraj, 2004; 
Tantracheewathorn & Tantracheewathorn, 2007). 
 In conjunction with the medical knowledge, the biomedical 
engineering perception was enrolled to assist the clinicians for predicting 
and investigating the risk in dengue patients (Abdul Rahim, 
Ibrahim, & Taib, 2006; Faisal, Ibrahim, & Taib, 2008a, 2008b; Ibrahim, 
2005; Ibrahim, Taib, Wan Abas, Chan, & Sulaiman, 2005b). The 
involvement of biomedical engineering was enrolled through bioelectrical 
impedance analysis (BIA) and artificial neural network 
(ANN). 
 BIA is a technique that evaluates the human body composition 
by passing tiny current through the human body. It has been used 
in dengue disease to classify the risk in DHF patients (Ibrahim, 
2005; Ibrahim et al., 2005a). The results showed that reactance is 
a potentially useful tool for classifying the risk factor of DHF 
patients. 
 ANN is a well established technique used widely in biomedical 
applications for modeling, analysis and diagnostic classification 
(Engin et al., 2007; Gil, Johnsson, Manuel, Soriano, & Ruiz, 2008; 
Icer, Kara, & Guven, 2006; Qiu, Tao, Tan, & Wu, 2007). Two types 
of artificial intelligence techniques were implemented in dengue 
disease field: supervised learning, namely, multilayer feed-forward 
neural networks (MFNN) (where the inputs and the outputs will be 
provided to the network for the training purpose) and unsupervised 
learning technique, namely, self-organizing map (SOM) 
(where only the inputs will be given). Ibrahim et al. (2005b) proposed 
a noninvasive prediction system for predicting the day of 
defervescence of fever in dengue patients using supervising learning. 
The study used the clinical symptoms and signs for predicting 
the day of defervescence of fever via MFNN. Ninety percent prediction 
accuracy was achieved in this study. Another study conducted 
by Abdul Rahim et al. (2006) was able to predict and model the 
haemoglobin concentration status in dengue patients using the linear 
autoregressive model (AR); with an accuracy of 76.70%. 
 SOM technique is an aid for visualizing, analyzing and understanding 
the complexity of high-dimensional data. It maps the data 
into a simple low-dimensional display to simplify the observation 
of the complexity of the data. In dengue disease, the SOM was used 
to identify the significant prognosis factors that discriminate between 
the dengue patients and the healthy subjects (Faisal et al., 
2008b). Moreover, the study conducted by Faisal et al. (2008a) employed 
SOM to obtain the significant risk criteria that can differentiate 
the dengue patients 
 Precise and efficient prediction of the level of risk in dengue is 
critical for clinical care, surveillance and lifesaving. Accordingly, 
the scope of the difficulties in dengue disease that most of the 
studies addressed includes the definition of the risk criteria in dengue 
disease and the prediction of the risk in dengue patients. Even 
though significant results were showed from some studies, a complete, 
systematic approach for predicting the risk in dengue disease 
has never been published yet. 
 This study presents the development of a noninvasive intelligent 
approach for predicting the risk in dengue patients. A combination 
of the SOM and MFNN was employed for this task. First, the 
SOM was employed for determining the correlated risk predictors 
from the clinical manifestations (symptoms/signs) and the bioelectrical 
impedance analysis (BIA) parameters, whereas the MFNN 
was used for constructing the prediction model using the correlated 
risk parameters. 
Methods 
Multilayer perceptron (MLP) 
 Generally, multilayer perceptron (MLP) consists of three main 
layers: input, hidden and output layers. Each layer is composed 
of a number of neurons chosen according to the system requirement. 
Generally, the number of the neurons in the input layer 
and the output layer is constantly predefined in such a way that 
they represent the numbers of inputs and the outputs of the system, 
respectively. The number of neurons in the hidden layer is 
variable, and it is be set experimentally. The neurons in all layers 
are fully connected through varying weights as shown in Fig. 1. 
 Initially, a set of data comprising input–output pairs, known as 
training data, are given to the network. The principle of the network 
is that when the inputs are presented to the first layer, the 
outputs are calculated for each consecutive layer. By comparing 
the last layer outputs and the desired outputs, the error is calculated. 
The training iterations or the learning process takes place 
by adjusting the values of the weights until an adequately small 
value of the error is obtained. 
Full text is available at : 
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